GPA
Garrison Point Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.05M | Sell |
32,771
-750
| -2% | -$47K | 0.94% | 26 |
|
2025
Q1 | $2.02M | Sell |
33,521
-480
| -1% | -$28.9K | 0.98% | 23 |
|
2024
Q4 | $1.98M | Buy |
34,001
+360
| +1% | +$21K | 0.94% | 24 |
|
2024
Q3 | $1.99M | Buy |
33,641
+506
| +2% | +$30K | 1.23% | 20 |
|
2024
Q2 | $1.86M | Buy |
33,135
+64
| +0.2% | +$3.59K | 1.23% | 20 |
|
2024
Q1 | $1.94M | Sell |
33,071
-10
| -0% | -$586 | 1.25% | 20 |
|
2023
Q4 | $1.79M | Buy |
33,081
+200
| +0.6% | +$10.8K | 1.26% | 21 |
|
2023
Q3 | $1.59M | Sell |
32,881
-414
| -1% | -$20.1K | 1.23% | 21 |
|
2023
Q2 | $1.88M | Sell |
33,295
-83
| -0.2% | -$4.69K | 1.35% | 17 |
|
2023
Q1 | $1.8M | Buy |
33,378
+15
| +0% | +$810 | 1.35% | 17 |
|
2022
Q4 | $1.75M | Sell |
33,363
-92
| -0.3% | -$4.84K | 1.43% | 18 |
|
2022
Q3 | $1.58M | Buy |
33,455
+186
| +0.6% | +$8.77K | 1.41% | 19 |
|
2022
Q2 | $1.68M | Sell |
33,269
-30
| -0.1% | -$1.51K | 1.39% | 20 |
|
2022
Q1 | $2.03M | Buy |
33,299
+124
| +0.4% | +$7.56K | 1.42% | 17 |
|
2021
Q4 | $2.19M | Buy |
33,175
+245
| +0.7% | +$16.1K | 1.45% | 17 |
|
2021
Q3 | $2.07M | Buy |
32,930
+27,425
| +498% | +$1.72M | 1.5% | 17 |
|
2021
Q2 | $1.99M | Hold |
5,505
| – | – | 1.43% | 15 |
|
2021
Q1 | $1.82M | Sell |
5,505
-25
| -0.5% | -$8.26K | 1.41% | 18 |
|
2020
Q4 | $1.81M | Sell |
5,530
-125
| -2% | -$40.9K | 1.46% | 17 |
|
2020
Q3 | $1.69M | Hold |
5,655
| – | – | 1.54% | 17 |
|
2020
Q2 | $1.5M | Sell |
5,655
-40
| -0.7% | -$10.6K | 1.48% | 18 |
|
2020
Q1 | $1.28M | Sell |
5,695
-285
| -5% | -$64.2K | 1.57% | 19 |
|
2019
Q4 | $1.58M | Buy |
5,980
+30
| +0.5% | +$7.93K | 1.45% | 21 |
|
2019
Q3 | $1.47M | Buy |
5,950
+30
| +0.5% | +$7.42K | 1.46% | 20 |
|
2019
Q2 | $1.43M | Buy |
5,920
+135
| +2% | +$32.5K | 1.43% | 24 |
|
2019
Q1 | $1.34M | Buy |
5,785
+115
| +2% | +$26.6K | 1.4% | 23 |
|
2018
Q4 | $1.13M | Buy |
+5,670
| New | +$1.13M | 1.4% | 20 |
|